Structures by: Suwińska K.
Total: 35
C39H30ClN3OOsP2
C39H30ClN3OOsP2
Physical Chemistry Chemical Physics (2019)
a=12.956(5)Å b=21.353(8)Å c=13.256(5)Å
α=90° β=110.133(16)° γ=90°
C39H32ClN3OOsP2,0.5(C3H7OH)
C39H32ClN3OOsP2,0.5(C3H7OH)
Physical Chemistry Chemical Physics (2019)
a=23.138(3)Å b=23.138(3)Å c=26.906(3)Å
α=90° β=90° γ=90°
C56H38O32S810,10(C12H9N2),2C2H6O,21H2O
C56H38O32S810,10(C12H9N2),2C2H6O,21H2O
CrystEngComm (2016) 18, 46 8858
a=34.8241(9)Å b=11.9401(2)Å c=41.747(1)Å
α=90.00° β=98.010(3)° γ=90.00°
C56H40O32S88,8(C12H9N21),15H2O
C56H40O32S88,8(C12H9N21),15H2O
CrystEngComm (2016) 18, 46 8858
a=18.0000(9)Å b=18.933(1)Å c=28.187(2)Å
α=76.131(2)° β=71.402(3)° γ=86.574(3)°
C56H36O32S811,5,11,5(C12H9N2),24H2O
C56H36O32S811,5,11,5(C12H9N2),24H2O
CrystEngComm (2016) 18, 46 8858
a=14.8749(4)Å b=20.9698(8)Å c=30.2225(9)Å
α=97.318(3)° β=99.924(2)° γ=95.529(3)°
C39H32ClN3OOsP2,H2O
C39H32ClN3OOsP2,H2O
Physical Chemistry Chemical Physics (2019)
a=18.170(4)Å b=11.651(2)Å c=16.431(3)Å
α=90° β=101.198(7)° γ=90°
[Os(Cl)(CO)(bpy)(tpp)2]+.PF6-.0.5toluene
C47H38N2OClOsP2,PF6,0.5C7H8
Physical chemistry chemical physics : PCCP (2016) 18, 41 28982-28996
a=28.557(2)Å b=28.557(2)Å c=11.9682(9)Å
α=90° β=90° γ=90°
[Os(H)(CO)(bpy)(tpp)2]+.PF6-.C7 H8
C47H39N2OOsP2,PF6,C7H8
Physical chemistry chemical physics : PCCP (2016) 18, 41 28982-28996
a=14.6490(7)Å b=14.7296(7)Å c=23.2685(12)Å
α=103.4470(10)° β=96.362(2)° γ=91.092(2)°
P-iso-propylcalix[4]arene
C40H48O4
CrystEngComm (2015) 17, 28 5129
a=24.851(3)Å b=9.4124(13)Å c=29.215(4)Å
α=90.00° β=103.211(2)° γ=90.00°
Form IIIp
C40H48O4
CrystEngComm (2015) 17, 28 5129
a=17.6812(15)Å b=9.5252(8)Å c=19.9837(17)Å
α=90.00° β=98.363(2)° γ=90.00°
Form Ip
C40H48O4
CrystEngComm (2015) 17, 28 5129
a=9.4324(11)Å b=15.3488(18)Å c=23.578(3)Å
α=90.00° β=98.751(2)° γ=90.00°
C38H40N2Ni,2(C4H8O)
C38H40N2Ni,2(C4H8O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7169-7176
a=9.0713(2)Å b=24.610(2)Å c=16.8975(5)Å
α=90° β=90° γ=90°
C44H52N2NiO
C44H52N2NiO
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7169-7176
a=17.1430(5)Å b=13.1907(2)Å c=17.5420(4)Å
α=90.00° β=114.528(3)° γ=90.00°
C33H36N2Ni
C33H36N2Ni
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7169-7176
a=10.6985(1)Å b=15.4023(1)Å c=16.7954(1)Å
α=90.00° β=96.035(1)° γ=90.00°
PW34
C42H46N2NiO
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7169-7176
a=13.0464(6)Å b=17.1568(8)Å c=15.5211(6)Å
α=90.00° β=101.257(2)° γ=90.00°
C38H40N2Ni
C38H40N2Ni
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7169-7176
a=13.4758(2)Å b=13.6096(2)Å c=17.1452(3)Å
α=90° β=105.054(2)° γ=90°
(C21H27N2)13,NiCl42,Cl1,6(CH2Cl2)
(C21H27N2)13,NiCl42,Cl1,6(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7169-7176
a=15.3884(4)Å b=15.3884(4)Å c=61.781(2)Å
α=90° β=90° γ=120°
C27H50O6
C27H50O6
Acta Crystallographica Section B (1996) 52, 3 550-554
a=6.234(2)Å b=15.628(3)Å c=30.749(10)Å
α=90.00° β=90.00° γ=90.00°
C16H36N2O4,2(F6P1)
C16H36N2O4,2(F6P1)
Acta Crystallographica Section C (1992) 48, 7 1234-1237
a=6.7000(10)Å b=20.911(9)Å c=9.609(2)Å
α=90° β=104.24(2)° γ=90°
C16H36N2O4,I2
C16H36N2O4,I2
Acta Crystallographica Section C (1992) 48, 7 1234-1237
a=6.4820(10)Å b=16.932(2)Å c=10.8710(10)Å
α=90° β=106.63(2)° γ=90°
3-[(2-hydroxyethoxy)methyl]-6-methyl-3H-imidazol[1,2-a]purin-9(5H)-one
C11H13N5O3.2H2O
Acta Crystallographica Section C (2001) 57, 6 767-769
a=8.4500(10)Å b=11.665(2)Å c=14.930(3)Å
α=75.44(2)° β=76.65(2)° γ=86.44(2)°
Streptidinium sulfate monohydrate
C8H20N6O42,O4S2,H2O
Acta Crystallographica Section C (2009) 65, 6 o290-o292
a=9.1105(5)Å b=9.1105(5)Å c=16.2506(7)Å
α=90.00° β=90.00° γ=120.00°
4-methyl-1,4-thiazino[2,3-c;6,5-c']diquinoline
C19H13N3S
Acta Crystallographica Section C (2000) 56, 3 374-375
a=11.848(3)Å b=11.015(4)Å c=12.313(4)Å
α=90.00° β=109.01(3)° γ=90.00°
1-Methyl-4(1H)-pyridinethione
C6H7N1S1
Acta Crystallographica Section C (2002) 58, 1 o32-o33
a=7.5440(10)Å b=9.0850(10)Å c=9.3020(10)Å
α=89.840(10)° β=84.030(10)° γ=87.980(10)°
2,6-dimethoxy-7,9-dimethylpurinium iodide hemihydrate
C9H13N4O2,I,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 4 o211-o213
a=6.9841(2)Å b=13.0977(4)Å c=28.3695(8)Å
α=90.00° β=90.00° γ=90.00°
10-(prop-2-yn-1-yl)dipyrido[3,4-<i>b</i>:3',4'-<i>e</i>][1,4]thiazine
C13H9N3S
Acta Crystallographica Section E (2012) 68, 6 o1590-o1591
a=14.1150(9)Å b=10.1909(6)Å c=7.6749(5)Å
α=90.00° β=104.212(3)° γ=90.00°
6-Acetylaminobutyl-9-chloroquino[3,2-<i>b</i>]benzo[1,4]thiazine
C21H20ClN3OS
Acta Crystallographica Section E (2012) 68, 12 o3324-o3325
a=12.7800(4)Å b=4.9530(11)Å c=28.781(2)Å
α=90.000° β=97.726(5)° γ=90.000°
6-[3-(<i>p</i>-Tolylsulfonylamino)propyl]diquinothiazine
C28H24N4O2S2
Acta Crystallographica Section E (2013) 69, 6 o972-o973
a=9.3986(3)Å b=10.3793(3)Å c=12.6207(3)Å
α=80.735(2)° β=81.959(2)° γ=77.999(2)°
C25H33LiNiO2
C25H33LiNiO2
Organometallics (2008) 27, 10 2346
a=9.8482(3)Å b=14.5816(4)Å c=15.6829(5)Å
α=90.00° β=90.00° γ=90.00°
Pw16
C31H48LiNiO7
Organometallics (2008) 27, 10 2346
a=31.21(3)Å b=11.851(7)Å c=17.44(2)Å
α=90.00° β=98.85(3)° γ=90.00°
PW19
C21H23LiNiO2
Organometallics (2008) 27, 10 2346
a=16.5651(5)Å b=14.5732(5)Å c=17.3587(3)Å
α=90.000(2)° β=116.770(2)° γ=90.0000(10)°
C34H26Ni3
C34H26Ni3
Organometallics (2008) 27, 13 3316
a=18.3002(3)Å b=9.1160(3)Å c=14.8054(6)Å
α=90.00° β=90.00° γ=90.00°
C22H20Ni
C22H20Ni
Organometallics (2008) 27, 14 3618
a=5.7888(2)Å b=13.1587(6)Å c=11.1799(5)Å
α=90.00° β=103.979(2)° γ=90.00°
C30H29Ni3
C30H29Ni3
Organometallics (2008) 27, 14 3618
a=12.505(6)Å b=9.792(5)Å c=19.219(8)Å
α=90.00° β=94.32(5)° γ=90.00°
C30H29Ni3
C30H29Ni3
Organometallics (2008) 27, 14 3618
a=16.393(6)Å b=9.319(5)Å c=17.292(7)Å
α=90.00° β=109.71(5)° γ=90.00°